BRMS1L antibody (AA 151-246) (Cy3)

Catalog No. ABIN730936

Product Details anti-BRMS1L Antibody (Cy3)

Target: BRMS1L (Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L))

Binding Specificity: AA 151-246

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This BRMS1L antibody is conjugated to Cy3

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Cross-Reactivity: Human

Predicted Reactivity: Mouse,Rat

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human BRMS-1

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for BRMS1L

Target: BRMS1L (Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L))

Alternative Name: BRMS-1 (BRMS1L Products)

Synonyms: BRMS1 antibody, 0710008O11Rik antibody, AI159718 antibody, D12Ertd407e antibody, MGC81249 antibody, brms1l antibody, im:7136473 antibody, zgc:114129 antibody, brms1 antibody, breast cancer metastasis-suppressor 1 like antibody, breast cancer metastasis-suppressor 1-like antibody, breast cancer metastasis-suppressor 1 like L homeolog antibody, breast cancer metastasis-suppressor 1-like a antibody, BRMS1L antibody, Brms1l antibody, brms1l.L antibody, brms1la antibody, brms1l antibody

Background:

Synonyms: Breast cancer metastasis-suppressor 1, BRMS1

Background: Transcriptional repressor. Down-regulates transcription activation by NF-kappa-B by promoting the deacetylation of RELA at 'Lys-310'. Promotes HDAC1 binding to promoter regions. Down-regulates expression of anti-apoptotic genes that are controlled by NF-kappa-B. Promotes apoptosis in cells that have inadequate adherence to a substrate, a process called anoikis, and may thereby inhibit metastasis. May be a mediator of metastasis suppression in breast carcinoma.

Gene ID: 25855

UniProt: Q9HCU9